Previous close | 226.27 |
Open | 227.65 |
Bid | 221.65 x 0 |
Ask | 221.90 x 0 |
Day's range | 225.05 - 227.65 |
52-week range | 203.98 - 239.70 |
Volume | |
Avg. volume | 2,844 |
Net assets | 216.05M |
NAV | 224.79 |
PE ratio (TTM) | N/A |
Yield | 0.00% |
YTD daily total return | -5.71% |
Beta (5Y monthly) | 0.74 |
Expense ratio (net) | 0.18% |
Inception date | 2014-12-05 |
SOPHIA-ANTIPOLIS, France, March 03, 2022--Median Technologies files FDA 513(g) regulatory submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device.
SOPHIA ANTIPOLIS, France, March 01, 2022--Median Technologies to participate in the Cowen’s 42nd Annual Health Care Conference